Dr. Broadwell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
820 Jordan Street
Suite 201
Shreveport, LA 71101Phone+1 318-221-0399Fax+1 318-221-1940
Education & Training
- Scripps Clinic/Scripps Green HospitalFellowship, Rheumatology, 2010 - 2012
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2007 - 2010
- Mayo Clinic College of Medicine and Science (Jacksonville)Residency, Internal Medicine, 2010
- University of Texas Medical Branch School of MedicineClass of 2007
Certifications & Licensure
- CA State Medical License 2009 - Present
- LA State Medical License 2012 - 2025
- FL State Medical License 2008 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
- National Board of Physicians and Surgeons Internal Medicine
Awards, Honors, & Recognition
- Fellow American College of Rheumatology
Publications & Presentations
PubMed
- 43 citationsLocalized vasculitis of the gastrointestinal tract: a case seriesCarlo Salvarani, Kenneth T. Calamia, Cynthia S. Crowson, Dylan V. Miller, Aaron W. Broadwell
Rheumatology. 2010-07-01 - 41 citationsDenosumab Safety and Efficacy Among Participants in the FREEDOM Extension Study With Mild to Moderate Chronic Kidney Disease.Aaron Broadwell, Arkadi Chines, Peter R. Ebeling, Edward Franek, Shuang Huang
The Journal of Clinical Endocrinology and Metabolism. 2021-01-23 - 1 citationsPopulation Pharmacokinetic and Exposure-Response Model Simulations: Predicted Exposure and Efficacy for Maintenance Doses of Intravenous Golimumab Every 6 or 8 Weeks i...Jong Bong Lee, Aaron Broadwell, Yijun Fan, Chuanpu Hu, Omoniyi J Adedokun
Clinical Therapeutics. 2022-03-01
Press Mentions
- Community Rheumatology Clinics: Pegloticase Safe & Effective with Any ImmunomodulatorNovember 30th, 2021
- 52-Week AWARE Results Show Efficacy, Safety of Rheumatoid Arthritis TherapiesSeptember 30th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: